1. Introduction
===============

Hepatitis B virus (HBV) is a small DNA virus consisting of a nucleocapsid which protects the 3.2 kb viral genome [@B1]. The nucleocapsid is surrounded by an envelope in which the major protein component is the 226 amino acid hepatitis B surface antigen (HBsAg). In addition to its involvement as an envelope protein of the infectious HBV particles, HBsAg is capable of forming into lipoprotein subviral particles (without the nucleocapsid and HBV genome) that are secreted from infected cells. Inappropriate secretion of HBsAg subviral particles with notably its intracellular storage has been clinically implicated in the pathogenesis of chronic hepatitis B [@B2].

One important step in HBV replication cycle is the viral morphogenesis, particularly the interaction between the nucleocapsid and HBsAg anchored at the endoplasmic reticulum, leading to envelopment and secretion of mature HBV particles [@B3]. Despite the recently reported investigation on the role of chaperones [@B4], little is known about general network of host cellular proteins that is needed for HBV morphogenesis. While conventional yeast two hybrid screening has been successful in isolating soluble cellular proteins interacting with a bait of interest [@B5], it can not be applied in the isolation of those interacting with transmembrane bait proteins such as HBsAg.

A yeast split-ubiquitin screening system for the characterization of membrane protein-protein interactions has been described [@B6]-[@B8]. We report in this study the application of this system to identify cellular membrane proteins interacting with HBsAg. The significance of our finding in the perspective of better understanding HBV morphogenesis is discussed.

2. Materials and methods
========================

Plasmids and reagents were contained in DUALmembrane Kit (DUALSystems Biotech, Switzerland).

2.1 Amplification and Cloning of HBsAg
--------------------------------------

The 678bp HBsAg gene was amplified by PCR using full length HBV DNA *(adw2* serotype*)* as the template. The oligonucleotide primers were designed as follows:

5\'-TTAGGCCTAAAAATGGAGAACATCACATCAGGA-3\'

5\'-AAAACAGAGACCCATATGTAAATTGGTACCAATT-3\'

The amplified PCR product was cloned into the binding domain vector pTMBV4 in-frame with Cub (the yeast ubiquitin). The construct was then used to transform yeast *S. cerevisiae* DSY-1 strain by LiOAc method.

2.2 Construction of cDNA Library from HBV-transfected HepG2 Cells
-----------------------------------------------------------------

### 2.2.1 Cell Culture and Transfection

Human hepatomacellular carcinoma cell line, HepG2, was grown in 12ml Dulbecco\'s Modified Eagle\'s Medium (DMEM) (Gibco) supplemented with 20% fetal calf serum and maintained in a saturated, humidified environment of 5% CO~2~ and 95% air at 37^o^C. The cell density when confluent was approximately 2 x 10^6^ HepG2 cells per 100mm dish. The replicative HBV genome was constructed by cloning a linear form of viral genome into mammalian expression vector pcDNA3.1 [@B9]. The linear genome, containing the viral promoter at its 5\' end and the region for termination of transcription at its 3\' end, was then transfected into these cells as described [@B9]. The ability of this genome in behaving as a replicative virus was assessed by the amount of HBsAg particles produced in the cell culture medium two days after its transfection into HepG2 cells, using ImX semi-quantitative measurement (Abbott Laboratories, USA).

Total RNA was extracted from these HBV-transfected HepG2 cells, and used as template for the synthesis of cDNA. The first strand cDNA was generated using random hexamer primer from BD Matchmaker™ Library Construction & Screening Kits User Manual (BD Biosciences, Clontech, USA). The second strand cDNA was synthesized using Long-Distance PCR (LD-PCR). The PCR mixture containing double stranded cDNA was purified using BD CHROMA SPIN^TM^ TE-400 Column.

### 2.2.2 Construction of cDNA Library in *S. cerevisiae*DSY-2 Strain

The cDNA library was prepared by transforming the yeast *S. cerevisiae*DSY-2 strain, in which the cDNA mixture was combined with pDL2-XN vector through homologous recombination. Yeast colony PCR was done for 22 randomly picked colonies to assess the size of cDNA insert. For each colony picked, half was streaked on SD/-Trp plate and the other half inoculated into a 20μl PCR mix.

Three ml of the freezing medium (SD/-Trp, 15% glycerol) was added to each plate and the yeast colonies were dislodged off the plates using a sterile loop. The suspension from each plate was then pooled together into a 1-litre sterile conical flask. The pooled suspension was given a mix by swirling before aliquoting into Falcon tubes proportionally for centrifugation at 700 x g for 5 minutes. The supernatant was discarded and the pellet was resuspended in half the original volume using Freezing medium. 1ml of cells were then aliquoted into ten 1.5ml microcentrifuge tubes, 10ml of cells were aliquoted into five 15ml tubes and the remaining cells aliquoted into 50ml Falcon tubes. The samples were then stored at -80^o^C.

2.3 Split-Ubiquitin Yeast Two Hybrid Screening
----------------------------------------------

### 2.3.1 Mating of *S. cerevisiae* DSY-1 (Bait) and *S. cerevisiae* DSY-2 (Prey)

The 1ml aliquot (≥2x10^7^ cells) frozen cDNA library was added to 5ml bait cells in a sterile 3-litre conical flask. The mixture was incubated at 30^o^C for 24 hours with gentle swirling at 30rpm. After 20 hours of mating, a drop of the mating culture was checked under a phase-contrast microscope at 400X magnification to check for the presence of 2 haploids. The culture was split into two 50ml Falcon tubes and centrifuged at 1000 x g for 10 minutes. The 3-litre flask used for mating was rinsed twice with 50ml of 0.5X YPDA/Kanamycin (50μg/ml) per rinsed. Each rinse (50ml) was used to resuspend one pellet. After resuspension, the tubes were centrifuged at 1000 x g for 10 minutes and the supernatant discarded. The pellet was resuspended in 5ml 0.5X YPDA/Kanamycin (50μg/ml) and combined into a total volume of 10ml.

To calculate the mating efficiency, 100μl of a 1: 10 000, 1: 1 000, 1: 100 and 1:10 dilutions of the mating mixture was spread onto SD/-Leu, SD/-Trp and SD/-Leu/-Trp agar plates. The remaining mating mixture was distributed evenly onto 5mM TDO-3AT plates with plating volume of 200μl. The plates were sealed and placed in a 30^o^C incubator for approximately 7 days.

### 2.3.2 Selection for *S. cerevisiae* Diploids Expressing Interacting Proteins

A total of fifteen colonies were selected for the first round of screening. Half of the colony was streaked on SD/-Trp agar plate and the other half inoculated into 20μl of PCR mix. PCR products were sequenced to determine the identity of the interacting proteins.

3. Results and Discussion
=========================

3.1 Principle of Split-Ubiquitin Screening System
-------------------------------------------------

Studies have shown that the use of yeast two hybrid system, which is a genetic assay for *in vivo* detection of interactions of proteins, enables identification of protein-protein interactions between a soluble bait and its interacting prey [@B5]. However, such a screening system is not suitable for the analysis of interaction between membrane bound proteins.

The split-ubiquitin yeast two hybrid system has been recently developed for the characterization of membrane protein interactions to overcome this limitation [@B6]-[@B8]. In this system, the ubiquitin is split into N-terminal ubiquitin (Nub) and C-terminal ubiquitin (Cub) but the Nub and Cub have high affinity towards each other and is able to reassemble back together spontaneously into ubiquitin protein. When Nub and Cub moieties bind together within a cell, this would activate the ubiquitin-specific protease (UBP) and hence, the transcriptional factor (TF) will be cleaved off. The cleaved TFs such as protein A-LexA-VP16 (PLV) will activate the expression of reporter genes (*LacZ*and *HIS3*) in the nucleus. The interaction between various membrane proteins will then be reflected by the activity of these reporter gene products, which can be measured similarly to the conventional yeast two hybrid system.

The bait protein, which is the HBsAg, is fused to a vector (pTMBV4) containing the Cub-reporter protein complex. The prey protein, which is the human malignant liver HepG2 cell transfected with HBV *adw2* serotype, is fused to vector (pDL2-XN) which contains a mutated NubG domain. The fusion plasmids are then cloned into the yeast cell and expressed on the cell membrane. If the prey protein interacts with the bait protein, this would bind the NubG and Cub domains together to form the ubiquitin complex.

This complex will then be recognized by UBPs and the TF that is located at the C terminus of Cub will be cleaved off and result in downstream reactions, which is the activation of *LacZ* and *HIS3* reporter genes [@B7].

3.2 Identification of Cellular Membrane Proteins Interacting with HBsAg
-----------------------------------------------------------------------

A number of cellular proteins have been isolated using the conventional yeast two hybrid screening [@B10], [@B11]. However, these reported HBV interacting proteins have all been isolated from normal liver cells that had not been exposed to HBV, which may reflect physical but physiologically not meaningful interactions. There is therefore a need to comprehensively isolate and characterize, in an environment, cellular proteins interacting not only with soluble HBV proteins, but also with membrane bound HBsAg.

To this end, a linearised form of HBV genome has been constructed in the mammalian expression vector pcDNA3.1 [@B9]. The linear HBV genome contained the viral promoter at its 5\' end and the region for termination of transcription at its 3\' end [@B9]. The ability of this genome in behaving as a replicative virus after its transfection in HepG2 cells was then measured by the amount of HBsAg particles secreted into cell culture medium two days after its transfection. Using the ImX semi-quantitative measurement, results in Table [1](#T1){ref-type="table"} suggested that HBsAg produced in the culture medium (rate of 65.8) was significantly higher than the negative control (normal culture medium with a rate of 4.3), but lower than the positive control (rate of 221.4). Our results suggested that a cellular environment exposed to HBV could be generated by transfecting a replicative HBV genome.

A cDNA library was therefore constructed from HBV-transfected HepG2 cells, using homologous recombination in yeast. PCR analysis on randomly selected colonies revealed a wide range of inserts from 250 bp (lanes, 2, 6 and 8, Fig. [1](#F1){ref-type="fig"}) to 1,500 bp (lane 10 and 13, Fig. [1](#F1){ref-type="fig"}). In addition, cDNA insert was detected in all selected colonies except colony 14. The wide range of cDNA inserts and absence of empty vector as shown in Fig. [1](#F1){ref-type="fig"} indicated that the cDNA library constructed in this study was suitable for the screening of cellular proteins interacting with HBsAg.

With HBsAg as bait, fifteen colonies were obtained from screening the above cDNA library using the yeast split-ubiquitin system. Sequence analysis revealed three interacting cellular membrane proteins as summarized in Table [2](#T2){ref-type="table"}.

While the role of the ER resident protein trx2 [@B13] in HBV morphogenesis remains to be elucidated, AP-2 and DAF have been implicated in virus infections [@B15], [@B17]. A major component of clathrin-associated adaptor protein complex that is involved in the clathrin-mediated endocytosis [@B14], AP-2 has also been involved in the downregulation of CD4 and MHC class I molecules by nef (a regulatory protein of HIV) thereby resulting in an increased HIV virulence [@B15]. On the other hand, the decay-accelerating factor (DAF) with its well-established role in the inhibition of activation of complement cascade [@B16] has recently been shown to be a co-receptor for coxackie B virus and involved in the transcytosis of the virus [@B17]. Further functional analysis of these HBsAg-interacting cellular membrane proteins should shed new insights on their role in HBV morphogenesis.
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![Determination of Size of Inserts in cDNA Library Constructed from HBV-transfected HepG2 Cells. The construction of this cDNA library from HBV-infected HepG2 cells was described in MATERIALS AND METHODS. Yeast colonies were selected randomly for PCR amplification. Size of individual inserts reflected by the size of the amplified PCR product was analysed on an agarose gel. Lane 1 to 22, PCR product from each of the 22 randomly selected colonies. Lane 1 kb DNA Ladder, DNA molecular weight marker](ijmsv02p0114g01){#F1}

###### 

Semi-Quantitative Measurement of HBsAg Following HBV-Transfection

                           Reaction Rate / Reactivity
  ------------------------ ----------------------------
  Replicative HBV Genome   65.8 / Reactive
  Positive Control         221.4 / Reactive
  Negative Control         4.3 / Non-Reactive

###### 

Summary of Cellular Membrane Proteins Interacting with HBsAg

  Clone   Cellular Membrane Protein                            Function                                                    Reference
  ------- ---------------------------------------------------- ----------------------------------------------------------- ----------------
  1       Thioredoxin-related transmembrane protein 2 (trx2)   Stimulate cell growth and prevent apoptosis                 [@B12], [@B13]
  3       Adaptor-related protein complex 2 (AP-2)             Clathrin-mediated endocytosis and protein sorting           [@B14], [@B15]
  4       Decay accelerating factor for complement (DAF)       Regulation of complement activation and virus co-receptor   [@B16], [@B17]
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